These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 11249591

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of action and resistance of older and newer fluoroquinolones.
    Hooper DC.
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S24-8. PubMed ID: 10984324
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanisms of resistance to fluoroquinolones.
    Rattan A.
    Natl Med J India; 1999 Aug; 12(4):162-4. PubMed ID: 10573971
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH, Wang JT, Chen YC, Chang SC, Luh KT.
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [Abstract] [Full Text] [Related]

  • 7. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R, Sato K, Kumita W, Inami N, Nishiyama H, Okamura N, Moriya K, Koike K.
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [Abstract] [Full Text] [Related]

  • 8. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
    Rolston KV, Yadegarynia D, Kontoyiannis DP, Raad II, Ho DH.
    Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular characterization of 8-methoxyfluoroquinolone resistance in a clinical isolate of methicillin-resistant Staphylococcus aureus.
    Horii T, Suzuki Y, Takeshita A, Maekawa M.
    Chemotherapy; 2007 May; 53(2):104-9. PubMed ID: 17202817
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV.
    Yun HJ, Min YH, Jo YW, Shim MJ, Choi EC.
    Int J Antimicrob Agents; 2005 Apr; 25(4):334-7. PubMed ID: 15784314
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Investigating the fluoroquinolone molecular resistant mechanism of Stenotrophomonas maltophilia].
    Tao CM, Lü XJ, Li P.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):266-9. PubMed ID: 16608091
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients.
    Ashour HM, el-Sharif A.
    J Clin Oncol; 2007 Dec 20; 25(36):5763-9. PubMed ID: 18089873
    [Abstract] [Full Text] [Related]

  • 18. Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects.
    Gootz TD, Brighty KE.
    Med Res Rev; 1996 Sep 20; 16(5):433-86. PubMed ID: 8865150
    [No Abstract] [Full Text] [Related]

  • 19. Mechanisms of quinolone resistance.
    Wiedemann B, Heisig P.
    Infection; 1994 Sep 20; 22 Suppl 2():S73-9. PubMed ID: 7927834
    [Abstract] [Full Text] [Related]

  • 20. Reversal of antibiotic resistance in Gram-positive bacteria by the antihistaminic azelastine.
    El-Nakeeb MA, Abou-Shleib HM, Khalil AM, Omar HG, El-Halfawy OM.
    APMIS; 2012 Mar 20; 120(3):215-20. PubMed ID: 22339679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.